Interaction of CTX-M-15 enzyme with cefotaxime: a molecular modelling and docking study
- 30 April 2010
- journal article
- Published by Biomedical Informatics in Bioinformation
- Vol. 4 (10) , 468-472
Abstract
Extendedspectrum βlactamases (ESBLs) are the bacterial enzymes that make them resistant to advanced-generation cephalosporins. CTXM enzymes (the most prevalent ESBLtype) target cefotaxime. Aims of the study were: Modelling of CTXM enzyme from blaCTXM sequences of clinical Escherichia coli isolatesDocking of cefotaxime with modelled CTXM enzymes to identify amino acid residues crucial to their interaction To hypothesize a possible relationship between ’interaction energy of the docked enzymeantibiotic complex‘ and ’minimum inhibitory concentration (MIC) of the antibiotic against the bacteria producing that enzyme‘. Seven E. coli strains of clinical origin which were confirmed as PCRpositive for blaCTXM were selected for the study. C600 cells harboring cloned blaCTXM were tested for ESBLproduction by doubledisksynergy test. BLAST analysis confirmed all the blaCTX-M genes as blaCTXM15. Four of the 7 strains were found to be clonally related. Modelling was performed using Swiss Model Server. Discovery Studio 2.0 (Accelrys) was used to prepare Ramachandran plots for the modelled structures. Ramachandran Zscores for modelled CTXM enzymes from E. coli strains D8, D183, D253, D281, D282, D295 and D296 were found to be 0.449, 0.096, 0.027, 0.043, 0.032, 1.249 and 1.107, respectively. Docking was performed using Hex 5.1 and the results were further confirmed by Autodock 4.0. The amino acid residues Asn 104, Asn132, Gly 227, Thr 235, Gly 236, and Ser237 were found to be responsible for positioning cefotaxime into the active site of the CTXM15 enzyme. It was found that cefotaxime MICs for the CTXM15producers increased with the increasing negative interaction energy of the enzymeantibiotic complex.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approachIndian Journal of Microbiology, 2009
- New Variant of CTX-M-Type Extended-Spectrum β-Lactamases, CTX-M-71, with a Gly238Cys Substitution in a K lebsiella pneumoniae Isolate from BulgariaAntimicrobial Agents and Chemotherapy, 2009
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Identification and characterization of ceftriaxone resistance and extended-spectrum β-lactamases in Malawian bacteraemic EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2006
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005
- Detection of CTX-M-15 extended-spectrum -lactamase in the United KingdomJournal of Antimicrobial Chemotherapy, 2003
- Acyl-intermediate Structures of the Extended-spectrum Class A β-Lactamase, Toho-1, in Complex with Cefotaxime, Cephalothin, and BenzylpenicillinJournal of Biological Chemistry, 2002
- Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in PolandJournal of Antimicrobial Chemotherapy, 2002
- Distribution of repetitive DNA sequences in eubacteria and application to finerpriting of bacterial enomesNucleic Acids Research, 1991
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988